Contagion&reg Editorial Staff

New research on Zika virus transmission leads some investigators to suggest that the virus should be labeled a sexually transmitted infection.

Hanneke Schuitemaker, PhD, explains the challenges faced when creating a vaccine for HIV.

Magda Opsomer, MD, shares the results of the Phase 3 EMERALD trial for darunavir.

Jessica Justman, MD, explains how decision makers can use the Population-based HIV Impact Assessment Project data.

In case you missed them, we've compiled the top 5 articles from this past week.

Viviane Boaventura, MD, MsC, PhD, discusses ongoing research related to auditory complications due to congenital Zika syndrome.

William D. O’Riordan, MD, FACEP, explains what makes iclaprim a unique antibiotic.

David Huang, PhD, MD, explains what the next steps are for iclaprim, an antibiotic developed to treat patients with acute bacterial skin and skin structure infections.

Alan Gross, PharmD, shares the drawbacks of some of the current prediction tools used for pneumonia.

Joergen Richt, DVM, PhD, discusses which animal models are being used to study Zika virus.

The US government’s new plan comes on the heels of reports that 5 African countries are poised to gain complete control over their HIV epidemics.

Lefamulin, a pleuromutilin antibiotic, continues to meet primary endpoints for the treatment of community acquired bacterial pneumonia (CABP) in clinical trials.

Doctors in the United Kingdom are recommending that antibiotics should be given to women who have preterm labor to avoid the transmission of group B streptococcal (GBS) disease to their newborns.

Alex Rinehart, PhD, explains if cabotegravir interacts with any other medications.

Silvia Munoz-Price, MD, PhD, explains how the undefined role of a hospital epidemiologist can be problematic.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Viviane Boaventura, MD, MsC, PhD, shares how past research has demonstrated that adults can experience Zika-associated hearing loss.

As practitioners continue to mistake the worsening of asthma symptoms for bacterial respiratory infections, more antibiotics are being prescribed, many times, inappropriately.

Silvio Pitlik, MD, visiting scientist, Weizmann Institute of Science, Israel, explains how the first Lyme disease patients were misdiagnosed.

Daniel Pilch, PhD, explains how the health care system must change in order to battle antibiotic resistance.

Alan Gross, PharmD, shares how an early diagnosis of multidrug-resistant pneumonia can work towards improving patient outcomes.

Joergen Richt, DVM, PhD, discusses the transmission cycle of Zika virus.

The CDC has launched an educational initiative called “Get Ahead of Sepsis,” which underscores the early recognition and timely treatment of sepsis.

Milena McLaughlin, PharmD, MSc, explains how officials test if a drug is counterfeit or active.

Meghan Jeffres, PharmD, shares what should be considered when considering the incorporation of penicillin skin testing into a health care facility.

Silvia Munoz-Price, MD, PhD, explains different elements that should be incorporated into training programs for hospital epidemiologists.

Alex Rinehart, PhD, identifies the target population for cabotegravir.

A herpes infection leads to deadly viral meningitis in an Iowa infant, an ingestible smart pill that can remind you to take your medications, global catastrophic biological risks, whether or not you should complete the full course of antibiotics, and all you need to know about Candida auris make up this week’s Top 5 articles.

Contagion® and MD Magazine together announce that they have expanded their Strategic Alliance Partnership program with Ochsner Health System.